These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 11178544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ, Clough NE.
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [Abstract] [Full Text] [Related]

  • 11. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E, Groen J, Uittenbogarrd J, van Herwijnen J, Osterhaus A.
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [Abstract] [Full Text] [Related]

  • 12. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulin.
    Gross S, Janssen SW, de Vries B, Terao E, Daas A, Buchheit KH.
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):11-25. PubMed ID: 20144449
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U, Noeske K, Werner E.
    ALTEX; 2005 Oct; 22(3):169-74. PubMed ID: 16186992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potency Testing of Swine Erysipelas Vaccines by Serology Results of a Pre-validation Study.
    Rosskopf-Streicher U, Johannes S, Wilhelm M, Gyra H, Cussler K.
    ALTEX; 1999 Oct; 16(3):123-128. PubMed ID: 11107318
    [Abstract] [Full Text] [Related]

  • 19. Establishment of the European Pharmacopoeia Biological Reference Preparation (Ph. Eur. BRP) for hepatitis A vaccine type B (Aventis Pasteur) batch 2.
    Buchheit KH, Daas A.
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):95-108. PubMed ID: 12448033
    [Abstract] [Full Text] [Related]

  • 20. Would an in vitro ELISA test be a suitable alternative potency method to the in vivo immunogenicity assay commonly used in the context of international Hepatitis A vaccines batch release?
    Poirier B, Variot P, Delourme P, Maurin J, Morgeaux S.
    Vaccine; 2010 Feb 17; 28(7):1796-802. PubMed ID: 20018270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.